Pharmaceutical compositions - 2 - Hydroxymethyl - 1.3 - oxatiolan - il - 5 - (1H) - pyrimidin-2-yl) - 2 - (mivudina ONA), and their use in Medical Therapy

摘要

A pharmaceutical component that is essentially free of ethanol and acetyldiimide, characterized by the presence of lamivudine or a pharmaceutically acceptable derivative, and a conservative regime. 1. Pharmaceutical ingredients, characterized by the presence of lamivudine, which is largely free of ethanol and ethyldiimide acetic acid, and meets the following specifications: (a) On the fourteenth day, the concentration of viable bacteria was reduced to no more than 0.1% of the initial concentration; (b). The concentrations of viable yeasts and molds are still at,Or less than the initial concentration within the first 14 days; and (c). For the remainder of the 28 day test period, the concentrations of each test microorganism were maintained at or below these specified concentrations.